Provalis (PVLS) Announces Update On Strategic Review
11/16/2005 1:50:09 PM
Provalis plc (LSE: PRO), the international medical diagnostics and pharmaceuticals group, is today providing an update on its previously announced strategic review. This review was initiated by the interim Chief Executive, Peter Woodford, following his appointment on 10 August 2005.
comments powered by